Jennifer McGovern Email

SVP Portfolio and Commercial Strategy, Oral Weekly Risperidone Program Leader . Lyndra Therapeutics

Current Roles

Employees:
111
Revenue:
$17.2M
About
TRANSFORMING THE WAY WE TAKE MEDICINE FOR A HEALTHIER WORLD ULTRA-LONG-ACTING ORAL DOSING IS ACHIEVABLE Our Team has developed the first ultra-long-acting pill that lasts a week or longer and can provide a wide range of medicines in a familiar oral capsule form. Once inside the stomach, the capsule delivers steady amounts of medicine for seven days or more. Our once-weekly product has safely demonstrated gastric residence with predictable pharmacokinetics in humans. There are no other oral products which provide ultra-long-acting therapeutic coverage or a controlled, steady delivery of medicine which can reduce side effects and improve drug efficacy, resulting in measurable health outcomes. At Lyndra, we ask “What if we stopped trying to change the patient and changed the pill instead?"​ Want to learn more? Please visit our website or contact us at info@lyndra.com. INSPIRED to Join Our Team? Check us out and apply! www.lyndra.com/join-our-team/ At Lyndra Therapeutics, we are INSPIRED by team members who are excited by innovation and growth, demonstrate strong technical expertise, and live our values. We are looking for people who will bring fresh ideas based on experience and who lead by adapting to the fast pace of an emerging biotech. In preparation for Phase 2 clinical development, we are looking to build our team in key areas in the near term : Clinical, Medical, Pre-clinical, Formulation, Process Development, Mechanical Engineering, and Manufacturing.
Lyndra Therapeutics Address
65 Grove St
Watertown, MA
United States
Lyndra Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.